David P. Luci
Chief Financial Officer, BIOENVISION INC.
Companies
- Acurx Pharmaceuticals, Inc.Board member Jun 24, 2021 to now1
- Acurx Pharmaceuticals, Inc.Chief executive officer Jun 24, 2021 to now1
- Acurx Pharmaceuticals, Inc.President Jun 24, 2021 to now1
- Enveric Biosciences, Inc.Board member Feb 14, 2018 to Aug 22, 20182
- PLx Pharma Winddown Corp.Board member Mar 12, 2014 to Apr 21, 20173
- PLx Pharma Winddown Corp.Chief executive officer Mar 12, 2014 to Jan 21, 20163
- PLx Pharma Winddown Corp.President Mar 12, 2014 to Jan 21, 20163
- ABEONA THERAPEUTICS INC.Board member Jan 8, 2007 to Nov 2, 20094
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Acurx Pharmaceuticals, Inc. ACXP1,132,458 shares5$1.3M at $1.13Jan 8, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 6, 2025Bought 49,261 shares at $1.02 of Acurx Pharmaceuticals, Inc.5
- Jan 3, 2024Exercised options 19,737 shares at $3.55 of Acurx Pharmaceuticals, Inc.6
- Jul 27, 2022Bought 19,737 shares at $3.80 of Acurx Pharmaceuticals, Inc.7
- Nov 19, 2021Bought 5,200 shares at $4.80 of Acurx Pharmaceuticals, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Jan 4, 2024
- 7SEC EDGARForm 4 filed Jul 29, 2022
- 8SEC EDGARForm 4 filed Nov 22, 2021